医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Fabrinet Announces Third Quarter 2013 Financial Results

2013年04月30日 AM05:40
このエントリーをはてなブックマークに追加


 

BANGKOK

Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced its financial results for the third quarter of fiscal 2013 ended March 29, 2013.

Fabrinet reported total revenue of $155.6 million for the third quarter of fiscal 2013, an increase of 11.9% compared to total revenue of $139.0 million for the comparable period in fiscal 2012. GAAP net income for the third quarter of fiscal 2013 was $21.1 million, or $0.61 per diluted share, compared to a GAAP net loss of ($46.3) million, or ($1.35) per diluted share, in the third quarter of fiscal 2012. Non-GAAP net income in the third quarter of fiscal 2013 was $11.5 million, or $0.33 per diluted share, an increase of 16.8% compared to non-GAAP net income of $9.9 million, or $0.28 per diluted share, in the same period a year ago.

Tom Mitchell, Chief Executive Officer of Fabrinet, said, “While overall industry demand remains muted, I am pleased that our third quarter results demonstrate the consistency of our operating model, with revenue and earnings per share performance above expectations. Our customer relationships remain strong and we continue to have success with new customers and new programs from existing customers. The net result is that we have continuing confidence in our ability to deliver profitable growth over the long-term.”

Business Outlook

Based on information available as of April 29, 2013, Fabrinet is issuing guidance for the fourth quarter of fiscal 2013 as follows:

Fabrinet expects fourth quarter revenue to be in the range of $148 million to $152 million. Non-GAAP net income per share is expected to be in the range of $0.26 to $0.28, assuming approximately 35 million fully diluted shares outstanding.

Conference Call Information

What:   Fabrinet Third Quarter 2013 Financial Results Conference Call
When: Monday, April 29, 2013
Time: 5:00 p.m. ET
Live Call: (888) 357-3694, domestic
(253) 237-1137, international
Passcode: 34166014
Replay: (855) 859-2056, domestic
(404) 537-3406, international
Passcode: 34166014

Webcast:

http://investor.fabrinet.com (live and replay)

 

This press release and any other information related to the call will also be posted on Fabrinet’s website at http://investor.fabrinet.com. A recorded version of this webcast will be available approximately two hours after the call and will be archived on Fabrinet’s website for a period of one year.

About Fabrinet

Fabrinet is a leading provider of advanced optical packaging and precision optical, electro-mechanical, and electronic manufacturing services to original equipment manufacturers of complex products, such as optical communication components, modules and subsystems, industrial lasers and sensors. Fabrinet offers a broad range of advanced optical and electro-mechanical capabilities across the entire manufacturing process, including process design and engineering, supply chain management, manufacturing, advanced packaging, integration, final assembly and test. Fabrinet focuses on production of high complexity products in any mix and any volume. Fabrinet maintains engineering and manufacturing resources and facilities in Thailand, the People’s Republic of China and the United States. For more information visit: www.fabrinet.com.

Forward-Looking Statements

“Safe Harbor” Statement Under U.S. Private Securities Litigation Reform Act of 1995

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include all of the statements under the “Business Outlook” section relating to our forecasted operating results for the fourth quarter of fiscal 2013. These forward-looking statements involve risks and uncertainties, and actual results could vary materially from these forward-looking statements. Important factors that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: less customer demand for our products and services than forecasted; less growth in the optical communications, industrial lasers and sensors markets than we forecast; difficulties expanding into additional markets, such as the semiconductor processing, biotechnology, metrology and materials processing markets; increased competition in the optical manufacturing services markets; difficulties in delivering products and services that compete effectively from a price and performance perspective; our reliance on a limited number of customers and suppliers; difficulties in accurately forecasting demand for our services; difficulties in managing our operating costs; difficulties in managing and operating our business across multiple countries (including the U.S., Thailand and the People’s Republic of China); and other important factors as described in reports and documents we file from time to time with the Securities and Exchange Commission (SEC), including the factors described under the section captioned “Risk Factors” in our quarterly report on Form 10-Q, filed on February 5, 2013. We disclaim any obligation to update information contained in these forward-looking statements whether as a result of new information, future events, or otherwise.

Use of Non-GAAP Financials

The Company refers to the non-GAAP financial measures cited above in making operating decisions because they provide meaningful supplemental information regarding the Company’s ongoing operational performance. Non-GAAP net income excludes share-based compensation expenses, income (expense) related to flooding and follow-on offering expenses. We have excluded these items in order to enhance investors’ understanding of our ongoing operations. The use of these non-GAAP financial measures has material limitations because they should not be used to evaluate our company without reference to their corresponding GAAP financial measures. As such, we compensate for these material limitations by using these non-GAAP financial measures in conjunction with GAAP financial measures.

These non-GAAP financial measures are used to: (1) measure company performance against historical results, (2) facilitate comparisons to our competitors’ operating results, and (3) allow greater transparency with respect to information used by management in financial and operational decision making. In addition, these non-GAAP financial measures are used to measure company performance for the purposes of determining employee incentive plan compensation.

Fabrinet
Unaudited Condensed Consolidated Balance Sheets
As of March 29, 2013 and June 29, 2012
   
(in thousands of U.S. dollars, except share data)

March 29,
2013

June 29,
2012

 
Assets
Current assets
Cash and cash equivalents $ 157,479 $ 115,507
Trade accounts receivable, net 122,926 128,253
Inventory, net 94,310 103,223
Deferred tax assets 2,158 4,088
Prepaid expenses 2,605 3,571
Other current assets 7,593 6,029
Total current assets 387,071 360,671
Non-current assets
Property, plant and equipment, net 98,173 97,923
Intangibles, net 196 380
Deferred tax assets 2,435 1,764
Deposits and other non-current assets 655 624
Total non-current assets 101,459 100,691
Total assets $ 488,530 $ 461,362
Liabilities and Shareholders’ Equity
Current liabilities
Long-term loans from bank, current portion $ 9,668 $ 9,668
Trade accounts payable 74,329 86,000
Construction-related payable 2,222
Income tax payable 1,171 353
Deferred tax liability 1,761 1,405
Accrued payroll, bonus and related expenses 7,442 5,181
Accrued expenses 3,254 2,630
Other payables 4,760 6,601
Liabilities to third parties due to flood losses 48,390 61,198
Total current liabilities 150,775 175,258
Non-current liabilities
Long-term loans from bank, non-current portion 21,660 28,911
Severance liabilities 5,464 4,420
Other non-current liabilities 1,618 2,064
Total non-current liabilities 28,742 35,395
Total liabilities 179,517 210,653
Commitments and contingencies
Shareholders’ equity

Preferred shares (5,000,000 shares authorized, $0.01 par value; no shares issued and outstanding as of March 29, 2013 and June 29, 2012)

Ordinary shares (500,000,000 shares authorized, $0.01 par value; 34,626,335 shares and 34,470,829 shares issued and outstanding as of March 29, 2013 and June 29, 2012, respectively)

346 345
Additional paid-in capital 69,938 65,462
Retained earnings 238,729 184,902

Total shareholders’ equity

309,013 250,709
Total Liabilities and Shareholders’ Equity $ 488,530 $ 461,362
 
 
Fabrinet
Unaudited Condensed Consolidated Statements of Operations
For the three and nine months ended March 29, 2013 and March 30, 2012
     
Three Months Ended Nine Months Ended
March 29,   March 30, March 29,   March 30,
(in thousands of U.S. dollars, except share data) 2013 2012 2013 2012
 
Revenues $ 155,557 $ 139,019 $ 481,608 $ 421,975
Cost of revenues (139,302 ) (124,138 ) (429,261 ) (375,281 )
Gross profit 16,255 14,881 52,347 46,694
Selling, general and administrative expenses (6,801 ) (6,586 ) (18,447 ) (18,543 )
Income (expense) related to flooding 11,419   (55,623 ) 21,064   (95,888 )
Operating income (loss) 20,873 (47,328 ) 54,964 (67,737 )
Interest income 302 209 761 628
Interest expense (239 ) (64 ) (788 ) (206 )
Foreign exchange gain, net 978 714 1,085 1,314
Other income 139   57   512   213  
Income (loss) before income taxes 22,053 (46,412 ) 56,534 (65,788 )
Income tax (expense) benefit (927 ) 87   (2,707 ) 1,864  
Net income (loss) $ 21,126   $ (46,325 ) $ 53,827   $ (63,924 )
 
Earnings (loss) per share
Basic $ 0.61 $ (1.35 ) $ 1.56 $ (1.86 )
Diluted 0.61 (1.35 ) 1.55 (1.86 )
 
Weighted average number of ordinary shares outstanding
(thousands of shares)
Basic 34,596 34,440 34,532 34,353

Diluted

34,909

34,440

*

34,794

34,353

*

 

 

 

 

 

 

* In accordance with the antidilutive provisions of ASC 260-10-45, basic and dilutive shares are the same for the period ended March 30, 2012

<td class="bwpadl0 bwnowrap bwpadr0 bwve

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Chi-Med Initiates Fruquintinib U.S. Clinical Trials
  • Orthocell Granted European Tendon Regeneration Patent
  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
  •  
    Fabrinet
    Unaudited Condensed Consolidated Statements of Cash Flows
    For the nine months ended March 29, 2013 and March 30, 2012
     
    Nine Months Ended
    March 29,   March 30,
    (in thousands of U. S. dollars) 2013 2012
     
    Cash flows from operating activities
    Net income (loss) for the period $ 53,827 $ (63,924 )
    Adjustments to reconcile net income to net cash provided by operating activities
    Depreciation 7,512 6,995
    Amortization of intangibles 185 288
    Gain on disposal of property, plant and equipment (23 ) (7 )
    Income related to flooding (21,064 )
    Proceeds from insurers for business interruption losses related to flooding 4,741
    Proceeds from insurers for inventory losses related to flooding 11,419
    (Reversal of) allowance for doubtful accounts (94 ) 28
    Unrealized gain on exchange rate and fair value of derivative (1,566 ) (1,364 )
    Share-based compensation 3,969 3,930
    Deferred income tax 1,615